Machine-learning-guided development of GLP-1R agonists

• In: New biologics and biosimilars: The new biologics and biosimilars: Advances in peptide drug design and GLP-1 agonists on Tuesday, 2 September 2025, 14:30-16:00
• At: Copenhagen (Denmark) (2025)
• Type: Presentation
• By: NIELSEN, Jens Christian
• Abstract:

  Antimicrobial resistance (AMR) is a growing concern in healthcare, posing a significant threat to effectively treating infections, leading to increases in patient illness, mortality, and healthcare costs. Bacteria exposed to antibiotics will inevitably develop resistance. To improve patient outcomes, slow down resistance development, and extend..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login